Patents by Inventor Kanghua WANG

Kanghua WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240072493
    Abstract: A chip slot is disclosed, which includes a slot, where a plurality of terminal groups are disposed in the slot, terminals in each terminal group include metal sheets that are symmetrically disposed on two opposite inner side walls of the slot, and each metal sheet has a bending pin that extends outside the slot; bending directions of bending pins on the terminals in each terminal group are same; and for any row of metal sheets in any two adjacent terminal groups, along an arrangement direction of the row of metal sheets, bending pins of the metal sheets in the adjacent terminal groups are alternately arranged on both sides of the row of metal sheets. The bending pins of the row of metal sheets are bent toward two different directions.
    Type: Application
    Filed: September 8, 2023
    Publication date: February 29, 2024
    Inventors: Tianren LIU, Kanghua OU, Yuanbin CAI, Junwei ZHONG, Xianfeng CHEN, Feng WANG, Zhiwei ZHANG
  • Publication number: 20220323525
    Abstract: The present invention discloses Fuke Qianjin Tablets and a quality control method therefor. The Fuke Qianjin Tablets are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Tablets contains not less than 0.008 mg of the genistin, not less than 0.7 mg of the Z-ligustilide, and the total amount of the andrographolide and the dehydroandrographolide is not less than 1.1 mg.
    Type: Application
    Filed: January 14, 2020
    Publication date: October 13, 2022
    Applicant: QIANJIN PHARMACEUTICAL CO., LTD.
    Inventors: Duanyu JIANG, Peng ZHANG, Yun GONG, Fujun LI, Yingshuai ZHANG, Lu BAI, Wei ZHAO, Kanghua WANG, Xiuwei YANG
  • Publication number: 20220143125
    Abstract: The present invention discloses Fuke Qianjin Capsules and a quality control method therefor. The capsules are made of Radix Et Caulis Flemingiae, Caulis Mahoniae, Herba Andrographis, Zanthoxylum dissitum Hemsl., Caulis Spatholobi, Radix Angelicae Sinensis, Radix Codonopsis, and Radix Rosa Laevigata as raw materials. Each of the Fuke Qianjin Capsules contains not less than 2.0 mg of Z-ligustilide, and a total amount of andrographolide and dehydroandrographolide is not less than 1.9 mg. A new standard for controlling quality of the Fuke Qianjin Capsules has been established through an analysis of chemical ingredients in the Fuke Qianjin Capsules. This standard adds a variety of core ingredient content to the existing pharmacopoeia standards. According to the Fuke Qianjin Capsules made in this range, the consistency of effects between different batches is more stable. Moreover, the more the types of core ingredients are limited, the more stable the consistency of the drug effect.
    Type: Application
    Filed: January 14, 2020
    Publication date: May 12, 2022
    Applicant: QIANJIN PHARMACEUTICAL CO., LTD.
    Inventors: Shun JIAN, Yun GONG, Peng ZHANG, Fujun LI, Yonggen LING, Juanjuan HE, Kanghua WANG, Xiuwei YANG